chr11-66070599-AGCAGCAGCCGCC-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_018026.4(PACS1):βc.124_135delβ(p.Pro42_Pro45del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000138 in 1,517,128 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (β ).
Frequency
Genomes: π 0.000099 ( 0 hom., cov: 32)
Exomes π: 0.0000044 ( 0 hom. )
Consequence
PACS1
NM_018026.4 inframe_deletion
NM_018026.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.12
Genes affected
PACS1 (HGNC:30032): (phosphofurin acidic cluster sorting protein 1) This gene encodes a protein with a putative role in the localization of trans-Golgi network (TGN) membrane proteins. Mouse and rat homologs have been identified and studies of the homologous rat protein indicate a role in directing TGN localization of furin by binding to the protease's phosphorylated cytosolic domain. In addition, the human protein plays a role in HIV-1 Nef-mediated downregulation of cell surface MHC-I molecules to the TGN, thereby enabling HIV-1 to escape immune surveillance. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 11-66070599-AGCAGCAGCCGCC-A is Benign according to our data. Variant chr11-66070599-AGCAGCAGCCGCC-A is described in ClinVar as [Likely_benign]. Clinvar id is 2274407.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 15 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PACS1 | NM_018026.4 | c.124_135del | p.Pro42_Pro45del | inframe_deletion | 1/24 | ENST00000320580.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PACS1 | ENST00000320580.9 | c.124_135del | p.Pro42_Pro45del | inframe_deletion | 1/24 | 1 | NM_018026.4 | P2 | |
PACS1 | ENST00000527224.1 | n.248_259del | non_coding_transcript_exon_variant | 1/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000989 AC: 15AN: 151694Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
15
AN:
151694
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000241 AC: 3AN: 124288Hom.: 0 AF XY: 0.0000282 AC XY: 2AN XY: 71028
GnomAD3 exomes
AF:
AC:
3
AN:
124288
Hom.:
AF XY:
AC XY:
2
AN XY:
71028
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000439 AC: 6AN: 1365324Hom.: 0 AF XY: 0.00000740 AC XY: 5AN XY: 676082
GnomAD4 exome
AF:
AC:
6
AN:
1365324
Hom.:
AF XY:
AC XY:
5
AN XY:
676082
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000988 AC: 15AN: 151804Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74196
GnomAD4 genome
AF:
AC:
15
AN:
151804
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74196
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at